Evidence map›Paper›PMID 38033415›Full record

ArticleCase reports in oncology

Fertility-Sparing Surgery in Infiltrative Mucinous Carcinoma of the Ovary.

Sarra Ben Ltaief, Montassar Ghalleb, Azza Chabchoub, Maher Slimen, Linda Hadj Kacem, Yosr Zenzeri, Riadh Chargui, Tarek Dhieb

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Sarra Ben LtaiefSurgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia.
Montassar GhallebSurgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia.
Azza ChabchoubSurgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia.
Maher SlimenSurgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia.
Linda Hadj KacemFaculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.
Yosr ZenzeriSurgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia.
Riadh CharguiSurgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia.
Tarek DhiebSurgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia.
Faculté de médecine de TunisInstitut Salah-Azaïz · TNTunis University · TNTunis El Manar University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Mucinous ovarian carcinoma is often diagnosed early and can affect young patients. The preservation of the female reproductive organ is one of the critical issues, especially for nulliparous women. This case report aims to reconsider the safe outcome of fertility-sparing surgery for infiltrative type mucinous ovarian carcinoma. Case Presentation: A 28-year-old woman with a right mucinous ovarian carcinoma, infiltrative subtype stage IA was treated by right salpingo-oophorectomy, omentectomy, and lymph nodes staging. A 5-year follow-up showed no signs of relapse, and she completed two full-term natural pregnancies. Conclusion: Conservative surgery is a crucial matter for this patient category. The infiltrative type has a poorer prognosis, but few papers have reported the outcome and the safety of fertility-sparing surgery in this context.

Indexed as

Expansile tumorFertilityInfiltrative carcinomaMucinous carcinomaSurgery

Identifiers

PMID38033415
PMCPMC10686631
OpenAlexW4389129307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.